Although one of the four GCRC1924 primary outgrowths established as a pan-KRT+/CD45− tumor and could be serially propagated as such, all P1 transplants of GCRC2034 were pan-KRT−/CD45+ and therefore this line was excluded from the final series. Here, PTPRC is linked to neoplasm.